Inventor · disambiguated record
Guy Hermans
Also filed as: HERMANS GUY
19 granted patents·33 pending applications·184 citations·filing 2006–2024
95Inventor score
Top patents by PatentIndex Score
52 records- 0197US10858418B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2020·Granted Dec 8, 2020·18 cites·20 claims
- 0295US8907065B2Polypeptides that modulate the interaction between cells of the immune systemHERMANS GUY·Filed 2007·Granted Dec 9, 2014·49 cites·34 claims
- 0394US8703135B2Biological materials related to c-MetBESTE GERALD·Filed 2012·Granted Apr 22, 2014·41 cites·26 claims
- 0493US10844123B2Amino acid sequences that modulate the interaction between cells of the immune systemABLYNX NV·Filed 2018·Granted Nov 24, 2020·4 cites·25 claims
- 0593US10087251B2Amino acid sequences that modulate the interaction between cells of the immune systemABLYNX NV·Filed 2016·Granted Oct 2, 2018·9 cites·21 claims
- 0693US9683045B2Biological materials related to c-MetABLYNX NV·Filed 2014·Granted Jun 20, 2017·17 cites·12 claims
- 0793US9346884B2Biological materials related to c-MetABLYNX NV·Filed 2012·Granted May 24, 2016·15 cites·5 claims
- 0892US11192937B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2017·Granted Dec 7, 2021·5 cites·6 claims
- 0992US11192938B2Serum albumin binding proteins containing immunoglobulin single variable domainsABLYNX NV·Filed 2017·Granted Dec 7, 2021·5 cites·35 claims
- 1089US11261260B2ADAMTS binding immunoglobulinsMERCK PATENT GMBH·Filed 2018·Granted Mar 1, 2022·4 cites·30 claims
- 1189US10208115B2Amino acid sequences that modulate the interaction between cells of the immune systemABLYNX NV·Filed 2016·Granted Feb 19, 2019·5 cites·25 claims
- 1289US2024182575A1Amino acid sequences that modulate the interaction between cells of the immune systemABLYNX NV·Filed 2023·Application pending·0 cites
- 1385US12006352B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2020·Granted Jun 11, 2024·1 cites·6 claims
- 1485US2023242620A1Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2023·Application pending·0 cites
- 1583US12129308B2MMP13 binding immunoglobulinsMERCK PATENT GMBH·Filed 2018·Granted Oct 29, 2024·2 cites·16 claims
- 1681US11644471B2Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2013·Granted May 9, 2023·2 cites·9 claims
- 1780US10072098B2Pseudomonas aeruginosa PCRV binding single variable domain antibodiesABLYNX NV·Filed 2013·Granted Sep 11, 2018·5 cites·25 claims
- 1880US2025257145A1ADAMTS Binding ImmunoglobulinsMERCK PATENT GMBH·Filed 2024·Application pending·0 cites
- 1976US11858997B2Amino acid sequences that modulate the interaction between cells of the immune systemABLYNX NV·Filed 2020·Granted Jan 2, 2024·0 cites·21 claims
- 2076US11603401B2Aggrecan binding immunoglobulinsABLYNX NV·Filed 2018·Granted Mar 14, 2023·2 cites·13 claims
- 2176US2025129183A1Mmp13 binding immunoglobulinsMERCK PATENT GMBH·Filed 2024·Application pending·0 cites
- 2272US12209136B2ADAMTS binding immunoglobulinsMERCK PATENT GMBH·Filed 2022·Granted Jan 28, 2025·0 cites·14 claims
- 2366US2018355031A1Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsABLYNX NV·Filed 2018·Application pending·0 cites
- 2466US2015266958A1Amino acid sequences that modulate the interaction between cells of the immune systemABLYNX NV·Filed 2014·Application pending·0 cites
- 2565US2023312694A1Aggrecan binding immunoglobulinsABLYNX NV·Filed 2022·Application pending·0 cites
- 2662US2018009888A9Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domainsBAUMEISTER JUDITH·Filed 2012·Application pending·0 cites
- 2758US11312788B2Pseudomonas aeruginosa PcrV binding single variable domain antibodiesABLYNX NV·Filed 2018·Granted Apr 26, 2022·0 cites·18 claims
- 2856US2011262427A1Amino acid sequences that modulate the interaction between cells of the immune systemABLYNX NV·Filed 2011·Application pending·0 cites
- 2953US2006246477A1Method for generating variable domain sequences of heavy chain antibodiesABLYNX NV·Filed 2006·Application pending·0 cites
- 3053US2006211088A1Method for generating variable domain sequences of heavy chain antibodiesABLYNX NV·Filed 2006·Application pending·0 cites
- 3151US2025082759A1Compositions comprising therapeutic nucleic acid and targeted saponin for the treatment of muscle-wasting disordersSAPREME TECH BV·Filed 2022·Application pending·0 cites
- 3251US2025250564A2Compositions comprising therapeutic nucleic acid and saponin for the treatment of muscle-wasting disordersSAPREME TECH BV·Filed 2022·Application pending·0 cites
- 3349US2023302140A1Conjugate of a single domain antibody, a saponin and an effector molecule, pharmaceutical composition comprising the same, therapeutic use of said pharmaceutical compositionSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 3449US2023277612A1Saponin derivatives for use in medicineSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 3549US2025295800A1Conjugate of a single domain antibody, a saponin and an effector molecule, pharmaceutical composition comprising the same, therapeutic use of said pharmaceutical compositionSAPREME TECH BV·Filed 2022·Application pending·0 cites
- 3649US2023293708A1Conjugate of saponin and single-domain antibody, pharmaceutical composition comprising said conjugate, therapeutic use thereofSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 3749US2023365617A1Saponin derivatives for use in medicineSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 3848US2025057971A1Targeted saponin-nucleic acid conjugates for treatment of muscle wasting disordersSAPREME TECH BV·Filed 2022·Application pending·0 cites
- 3947US2023248844A1Combination comprising an adc or an aoc comprising a vhh, and a saponin or a ligand-saponin conjugateSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 4046US2011059101A9Amino Acid Sequences Directed Against Il-6 And Polypetides Comprising The Same For The Treatment Of Diseases And Disorders Associated With Il-6 Mediated SignallingABLYNX NV·Filed 2007·Application pending·0 cites
- 4145US2023270872A1Conjugate of saponin and single-domain antibody, pharmaceutical composition comprising said conjugate, therapeutic use thereofSAPREME TECH BV·Filed 2020·Application pending·0 cites
- 4245US2024307545A1Conjugate of saponin, oligonucleotide and galnacSAPREME TECH BV·Filed 2022·Application pending·0 cites
- 4345US2023277680A1Conjugate of a single domain antibody, a saponin and an effector molecule, pharmaceutical composition comprising the same, therapeutic use of said pharmaceutical compositionSAPREME TECH BV·Filed 2020·Application pending·0 cites
- 4444US2024115712A1Semicarbazone-based saponin conjugateSAPREME TECH BV·Filed 2022·Application pending·0 cites
- 4543US2024066045A1Semicarbazone-based saponin conjugateSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 4642US2023256111A1Combination comprising an adc or an aoc comprising a vhh, and a saponin or a ligand-saponin conjugateSAPREME TECH BV·Filed 2020·Application pending·0 cites
- 4742US2023248845A1Combination of an antibody-drug conjugate and an antibody-saponin conjugateSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 4842US2023293562A1Therapeutic combination of galnac-oligonucleotide conjugate and saponin, and uses thereofSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 4942US2024115726A1Hydrazone-based saponin derivativesSAPREME TECH BV·Filed 2021·Application pending·0 cites
- 5041US2024327829A1Conjugate of saponin, oligonucleotide and galnacSAPREME TECH BV·Filed 2021·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Guy Hermans files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →